AI assistant
Elekta — Director's Dealing 2014
Oct 3, 2014
2906_rns_2014-10-03_7f0b79cf-194d-4e22-8889-b4dc3ba48a7d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Tomas Puusepp, Executive Director of the Board acquires shares
STOCKHOLM, October 3, 2014 – Tomas Puusepp, Executive Director of the Board of Elekta, has today acquired 20,000 shares in Elekta at a total value of approximately SEK 1.5 million.
#
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB Tel: +31 653 561 242, e-mail: [email protected]
Johan Andersson, Director, Investor Relations, Elekta AB Tel: +46 702 100 451, e-mail: [email protected]
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 13:30 CET on October 3, 2014.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resourceefficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.